• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于药物输送的口服式远程控制智能胶囊的最新技术和未来展望:GENEGUT 综述。

State-of-the-art and future perspectives in ingestible remotely controlled smart capsules for drug delivery: A GENEGUT review.

机构信息

School of Pharmacy, University College Cork, College Road, Cork, Ireland.

Tyndall National Institute, University College Cork, Cork T12R5CP, Ireland.

出版信息

Eur J Pharm Sci. 2024 Dec 1;203:106911. doi: 10.1016/j.ejps.2024.106911. Epub 2024 Sep 16.

DOI:10.1016/j.ejps.2024.106911
PMID:39293502
Abstract

An emerging concern globally, particularly in developed countries, is the rising prevalence of Inflammatory Bowel Disease (IBD), such as Crohn's disease. Oral delivery technologies that can release the active therapeutic cargo specifically at selected sites of inflammation offer great promise to maximise treatment outcomes and minimise off-target effects. Therapeutic strategies for IBD have expanded in recent years, with an increasing focus on biologic and nucleic acid-based therapies. Reliable site-specific delivery in the gastrointestinal (GI) tract is particularly crucial for these therapeutics to ensure sufficient concentrations in the targeted cells. Ingestible smart capsules hold great potential for precise drug delivery. Despite previous unsuccessful endeavours to commercialise drug delivery smart capsules, the current rise in demand and recent advancements in component development, manufacturing, and miniaturisation have reignited interest in ingestible devices. Consequently, this review analyses the advancements in various mechanical and electrical components associated with ingestible smart drug delivery capsules. These components include modules for device localisation, actuation and retention within the GI tract, signal transmission, drug release, power supply, and payload storage. Challenges and constraints associated with previous capsule design functionality are presented, followed by a critical outlook on future design considerations to ensure efficient and reliable site-specific delivery for the local treatment of GI disorders.

摘要

一个新兴的全球性关注问题,特别是在发达国家,是炎症性肠病(IBD)的发病率上升,如克罗恩病。能够将活性治疗有效负载专门递送到选定炎症部位的口服递药技术为最大限度地提高治疗效果和最小化非靶向效应提供了巨大的前景。近年来,IBD 的治疗策略不断扩展,越来越关注基于生物和核酸的治疗方法。这些治疗方法在胃肠道(GI)中可靠的部位特异性递药特别重要,以确保在靶向细胞中达到足够的浓度。可摄入的智能胶囊在精确药物递送上具有巨大的潜力。尽管以前在商业上开发药物递送智能胶囊的努力并不成功,但目前对需求的增加以及组件开发、制造和小型化方面的最新进展重新激发了对可摄入设备的兴趣。因此,本综述分析了与可摄入智能药物递送胶囊相关的各种机械和电气组件的进展。这些组件包括用于设备在 GI 道内定位、启动和保留的模块、信号传输、药物释放、电源和有效负载存储。介绍了与以前胶囊设计功能相关的挑战和限制,然后对未来设计考虑因素进行了批判性展望,以确保用于 GI 疾病局部治疗的高效和可靠的部位特异性递药。

相似文献

1
State-of-the-art and future perspectives in ingestible remotely controlled smart capsules for drug delivery: A GENEGUT review.用于药物输送的口服式远程控制智能胶囊的最新技术和未来展望:GENEGUT 综述。
Eur J Pharm Sci. 2024 Dec 1;203:106911. doi: 10.1016/j.ejps.2024.106911. Epub 2024 Sep 16.
2
Advances in oral nano-delivery systems for colon targeted drug delivery in inflammatory bowel disease: selective targeting to diseased versus healthy tissue.用于炎症性肠病结肠靶向给药的口服纳米给药系统进展:对病变组织与健康组织的选择性靶向
Nanomedicine. 2015 Jul;11(5):1117-32. doi: 10.1016/j.nano.2015.02.018. Epub 2015 Mar 14.
3
Nanoparticle-Mediated Drug Delivery Systems For The Treatment Of IBD: Current Perspectives.纳米颗粒介导的药物传递系统治疗炎症性肠病:当前的观点。
Int J Nanomedicine. 2019 Nov 13;14:8875-8889. doi: 10.2147/IJN.S210315. eCollection 2019.
4
Reactive oxygen species responsive nanoplatforms as smart drug delivery systems for gastrointestinal tract targeting.活性氧响应性纳米平台作为用于胃肠道靶向的智能药物递送系统
Biopolymers. 2020 Jan;111(1):e23336. doi: 10.1002/bip.23336. Epub 2019 Nov 14.
5
TARGIT technology: coated starch capsules for site-specific drug delivery into the lower gastrointestinal tract.TARGIT技术:用于将药物特异性递送至下消化道的包衣淀粉胶囊。
Expert Opin Drug Deliv. 2005 Jan;2(1):159-67. doi: 10.1517/17425247.2.1.159.
6
Nanoparticles for oral delivery: targeted therapy for inflammatory bowel disease.用于口服递送的纳米颗粒:炎症性肠病的靶向治疗。
J Mater Chem B. 2022 Aug 10;10(31):5853-5872. doi: 10.1039/d2tb01190e.
7
Orally ingestible medical devices for gut engineering.用于肠道工程的口服可食用医疗设备。
Adv Drug Deliv Rev. 2020;165-166:142-154. doi: 10.1016/j.addr.2020.05.004. Epub 2020 May 13.
8
A novel remote controlled capsule for site-specific drug delivery in human GI tract.一种新型遥控胶囊,用于人体胃肠道内的靶向药物输送。
Int J Pharm. 2009 Dec 1;382(1-2):160-4. doi: 10.1016/j.ijpharm.2009.08.026. Epub 2009 Aug 28.
9
Swallowable smart pills for local drug delivery: present status and future perspectives.可吞咽智能药丸用于局部药物输送:现状和未来展望。
Expert Rev Med Devices. 2015;12(5):585-99. doi: 10.1586/17434440.2015.1061933. Epub 2015 Jul 3.
10
Assessment of levetiracetam bioavailability from targeted sites in the human intestine using remotely activated capsules and gamma scintigraphy: Open-label, single-dose, randomized, four-way crossover study in healthy male volunteers.使用远程激活胶囊和γ闪烁照相术评估人体肠道特定部位的左乙拉西坦生物利用度:健康男性志愿者单次、随机、四交叉、开放标签研究。
Clin Ther. 2010 Sep;32(10):1813-21. doi: 10.1016/j.clinthera.2010.09.001.

引用本文的文献

1
4D-printed microdevices for spatiotemporal detection of ctDNA and miRNA in pancreatic cancer: an in-depth review.用于时空检测胰腺癌中ctDNA和miRNA的4D打印微型设备:深入综述
Med Oncol. 2025 Sep 3;42(10):462. doi: 10.1007/s12032-025-03021-8.